Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma
Myeloid neoplasm with rearrangement of PDGFRA , but with no significant eosinophilia: should we broaden the World Health Organization definition of the entity?
Management of multidrug-resistant viruses in the immunocompromised host
Telomere dysfunction and its role in haematological cancer
UK guidelines on the management of iron deficiency in pregnancy
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes
A new genetic abnormality leading to TP53 gene deletion in chronic lymphocytic leukaemia
Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents
Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study
The pan-histone deacetylase inhibitor CR2408 disrupts cell cycle progression, diminishes proliferation and causes apoptosis in multiple myeloma cells
Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients
Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a Paediatric Oncology Group study
Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant
Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population-based cohort study
CBL mutations in infant acute lymphoblastic leukaemia
Association of an increased frequency of CD14+HLA-DRlo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL)
Very elderly patients with essential thrombocythaemia: are they a separate category? A monocentric study on 118 patients older than 75 years
The peripheral CD138+ population but not the CD138− population contains myeloma clonogenic cells in plasma cell leukaemia patients
Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation
Stem cell migration: methods and protocols